Benitec Biopharma to present BB-301 clinical data at gene therapy meeting

April 28, 2026 7:00 AM

Benitec Biopharma Inc. (NASDAQ: BNTC) will present interim clinical results from its Phase 1b/2a study of BB-301 at the American ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found